Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: Potential association with Tourette syndrome substance abuse and other disorders

Pharmacogenetics

Volumn 6, Issue 4, 1996, Pages 307-318

  Comings, David E ^a   Gade, Radhika ^a   Muhleman, Donn ^a   Chiu, Connie ^a   Wu, Shijuan ^a   To, Michael ^a   Spence, Matthew ^a   Dietz, George ^a   Winn Deen, Emily ^b   Rosenthal, Richard J ^c   Lesieur, Henry R ^d   Rugle, Loreen ^e   Sverd, Jeffrey ^f   Ferry, Linda ^g   Johnson, James Patrick ^g   MacMurray, James P ^g  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b PERKINELMER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d I ^*  (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Sagamore Children's Psychiat Center   (United States)

^g Jerry L Pettis VA Hospital   (United States)

Author keywords

Oxygenase; Polymorphism; Serotonin; Tryptophan; Tryptophan 2,3 dioxygenase

Indexed keywords

FORMYLKYNURENINE; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD LEVEL; CELL LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE; EXON; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; MENTAL DISEASE; MONOAMINE METABOLISM; PRIORITY JOURNAL; PSYCHOSIS; SUBSTANCE ABUSE; THROMBOCYTE;

EID: 9544223224     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199608000-00004     Document Type: Article

References (38)

1. Brown S-L, van Praag HM. The role of serotonin in psychiatric disorders. New York: Brunner/Mazel, 1990: 1-348.
2. Comings DE, Comings BG, Knell E. Hypothesis: homozygosity in Tourette syndrome. Am J Med Genet 1989: 34, 413-421.
3. Comings DE. Tourette syndrome and human behavior. Duarte CA: Hope Press 1990a: 1-828.
4. Comings DE. Blood serotonin and tryptophan in Tourette syndrome. Am J Med Genet 1990b: 36, 418-430.
5. Comings DE. The haplotype relative risk technique lacks power in polygenic inheritance. 1995 World Congress Psychiatric Genetics 1995a: 5, 103.
6. Comings DE. The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their relatives. J Dev Behav Pediatr 1995b: 16, 142-157.
7. Comings DE. Genetic factors in depression based on studies of Tourette syndrome and Attention Deficit Hyperactivity Disorder probands and relatives. Am J Med Genet (Neuropsych Genet) 1995c: 60, 111-121.
8. Comings DE, Muhleman D, Dietz GW, Donlon T. Human tryptophan oxygenase localized to 4q31: Possible implications for human behavioral disorders. Genomics 1991: 9, 301-308
9. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug and Alcohol Dependence 1994: 34, 175-180.
10. Comings DE, Muhleman D, Dietz G, Sherman M, Forest G. Sequence of human tryptophan 2,3-dioxygenase: presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics 1995: 29, 390-396.
11. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 1996a: 6, 73-79.
12. Comings DE, Rosenthal RJ, Lesieur HR, Rugle L, Muhleman D, Chiu C, Dietz G, Gade R. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996b: (in press).
13. Comings DE, Wu H, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct and oppositional defiant disorder: The additive and subtractive effect of three dopaminergic genes - DRD2, DbH and DATA. Am J Med Gen (Neuropsych Genet) 1996c: 67, 264-288.
14. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. American Psychiatric Association, Washington, DC, 1987.
15. Dursun SM, Farrar G, Handley SL, Rickards H, Betts T, Corbett JA. Elevated plasma kynurenine in Tourette syndrome. Molec Chem Neuropathy 1994: 21, 55-60.
16. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987: 51, 227-233.
17. Glavac D, Dean M. Optimization of the single-strand conformation polymorphisms (SSCP) technique for detection of point mutations. Human Mutation 1991: 2, 404-414.
18. Grey MR. Detection of DNA sequence polymorphisms in human genomic DNA by using denaturing gradient gel blots. Am J Med Genet 1992: 50, 331-346.
19. Grossman PD, Bloch W, Brinson E, Chang CC, Eggerding FA, Fung S, Iovannisci DA, Woo S, Winn-Deen ES. High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Res 1994: 22, 4527-4534.
20. Hanley HG, Stahl SM. Freedman DX. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 1977: 34, 521-531.
21. Hayaishi O. Properties and function of indoleamine 2,3-dioxygenase. J Biochem 1976: 79, 13-21.
22. Hongyo T, Buzzard GS, Culvert RJ, Weghorst CM. 'Cold SSCP': A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acid Res 1993: 21, 3637-3642.
23. Hoshino Y, Yamamoto T, Kaneko M, Tachibana R, Watanabe M, Ono Y, Kumashiro H. Blood serotonin and free tryptophan concentration in autistic children. Neuropsychobiology 1984: 11, 22-27.
24. Hoton TA, Graham MW. Simple and efficient method for direct cloning of PCR products using ddT-tailed vectors. Nucleic Acids Res 1991: 19, 1156.
25. Kaltschmidt C, Muller M, Brem G, Renkawitz R. DNAase I hypersensitive sites far upstream of the rat tryptophan oxygenase gene direct developmentally regulated transcription in livers of transgenic mice. Mechanisms of Development 1994: 45, 203-210.
26. Landegren ÜL, Kaiser R, Hood L. A ligase-mediated gene detection technique. Science 1988: 241, 1077-1080.
27. LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alchohol intake, abuse and dependence: findings of animal studies. Biol Psychiatry 1994a: 36, 395-421.
28. LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse and dependence: Clinical evidence. Biol Psychiatry 1994b: 36, 326-337.
29. Lewontin RC, Kojima K-I. The evolutionary dynamics of coplex polymorphisms. Evolution 1960: 14, 458-472.
30. Lewontin RC. The interaction of selection and linkage. I. General considerations: heterotic models. Genetics 1964: 49, 49-67.
31. Merkulov VM, Merkulova TI. Nucleotide sequence of a fragment of the rat tryptophan oxygenase gene showing high affinity to glucocorticoid receptor in vitro. Biochim Biophys Acta 1992: 1132, 100-102.
32. Najfeld V, Menniger J, Muhleman D, Comings DK, Gupta SL. Localization of indoleamine 2,3-dioxygenase gene to chromosome 8p12-p11 by fluorescent in situ hybridization. Cytogenetics Cell Genetics 1993: 64, 231-232.
33. Okayama H, Curiel DT, Brantly ML, Holmes MD, Crystal RG. Rapid nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med 1989: 114, 105-113.
34. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989: 5, 874-879.
35. Propping P, Nöthen MM, Fimmers R, Baur MP. Linkage versus association studies in complex diseases. Psychiat Genet 1993: 3, 136.
36. Ritvo ER, Yuwiler A, Geller K, Ornitz EM, Saeger K, Plotkin S. Increased blood serotonin and platelets in early infantile autism. Arch Gen Psychiatry 1970: 23, 566-572.
37. Rothman KKJ. No adjustments are needed for multiple comparisons. Epidemiology 1990: 1, 43-46.
38. Ugozzoli L, Wallace RB. Allele-specific polymerase chain reaction. Methods: A Companion to Methods Enzymol 1991: 2, 42-48.